Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eptifibatide vs tirofiban in high-risk ACS PCI patients
CTR20140788Phase 3Active
- Sponsor
- Hainan Shuangcheng Pharmaceuticals
- Start
- Nov 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of eptifibatide in acute coronary syndrome (ACS), sponsored by Hainan Shuangcheng Pharmaceuticals. Started Nov 2014; status: active.
02
Drugs
eptifibatide
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on CTR20140788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140788.